COLYPAN® (Trimebutine)

Composition:

Trimebutine

Indications:

Irritable Bowel Syndrome (IBS) and associated abdominal pain. Management of bowel transit disorders associated with IBS, including diarrhea, constipation, and mixed presentations.

Dosage:

Oral treatment: 600 mg daily.

Presentation:

• Trimebutine 200 mg, box of 30 film-coated tablet
• Trimebutine 300 mg prolonged-release tablets, box of 20 tablets

Prescription Only.